Therapy of NAFLD: insulin sensitizing agents.

Therapy of NAFLD: insulin sensitizing agents.

Item
http://www.wikidata.org/entity/Q30439790
Metformin in nonalcoholic steatohepatitis: a randomized controlled trialThe C-681G polymorphism of the PPAR-γ gene is associated with susceptibility to non-alcoholic fatty liver disease.Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis.Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT studyTreatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes.Endoplasmic reticulum stress upregulates protein tyrosine phosphatase 1B and impairs glucose uptake in cultured myotubesNuclear receptors as therapeutic targets in cholestatic liver diseases.Clinical approaches to non-alcoholic fatty liver diseaseLong-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet.
P2860

Therapy of NAFLD: insulin sensitizing agents.

Item
http://www.wikidata.org/entity/Q30439790
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Therapy of NAFLD: insulin sensitizing agents.
@ast
Therapy of NAFLD: insulin sensitizing agents.
@en
type
label
Therapy of NAFLD: insulin sensitizing agents.
@ast
Therapy of NAFLD: insulin sensitizing agents.
@en
prefLabel
Therapy of NAFLD: insulin sensitizing agents.
@ast
Therapy of NAFLD: insulin sensitizing agents.
@en
P1433
P1476
P2093
P304
P31
P356
P478
P577
P698
P921
P356
P1433
P1476
Therapy of NAFLD: insulin sensitizing agents.
@en
P2093
P304
P31
P356
10.1097/01.MCG.0000168647.71411.48
P478
P577
P698
P921